14 Analysts Have This to Say About Boston Scientific
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 14 analysts have published their opinion on Boston Scientific (NYSE:BSX) stock, with an average price target of $57.29, implying an upside from the current price of $51.06. The current average has increased by 7.75% from the previous average price target of $53.17.
May 30, 2023 | 12:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
14 analysts have published their opinion on Boston Scientific (NYSE:BSX) stock, with an average price target of $57.29, implying an upside from the current price of $51.06.
The average price target of $57.29, which is higher than the current price of $51.06, indicates a positive outlook for the stock. The increase in the average price target by 7.75% from the previous average of $53.17 also suggests growing confidence among analysts. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100